|
"yen c j"的相关文件
显示项目 346-370 / 471 (共19页)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Tsou H.-H.; CHIUN HSU; Yen C.-J.; Yang S.-H.; Chen M.-H.; Chiang N.-J. |
| 國立成功大學 |
2020 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, Y.-S.;Chen, L.-T.;Wu, J.-S.;Chang, Y.-F.;Lee, C.-T.;Wu, C.-H.;Chiang, N.-J.;Huang, Huang H.-E.;Yen, C.-J.;Chao, Y.-J.;Tsai, H.-J.;Chen, Chen C.-Y.;Kang, J.-W.;Kuo, C.-F.;Tsai, C.-R.;Weng, Y.-L.;Yang, H.-C.;Liu, H.-C.;Chang, J.S. |
| 國立成功大學 |
2020 |
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
|
Yen, C.-J.;Kiyota, N.;Hanai, N.;Takahashi, S.;Yokota, T.;Iwae, S.;Shimizu, Y.;Hong, R.-L.;Goto, M.;Kang, J.-H.;Li, W.S.K.;Ferris, R.L.;Gillison, M.;Endo, T.;Jayaprakash, V.;Tahara, M. |
| 國立成功大學 |
2020 |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de, Bono J.;Lin, C.-C.;Chen, L.-T.;Corral, J.;Michalarea, V.;Rihawi, K.;Ong, M.;Lee, J.-H.;Hsu, C.-H.;Yang, J.C.-H.;Shiah, H.-S.;Yen, C.-J.;Anthoney, Anthoney A.;Jove, M.;Buschke, S.;Fuertig, R.;Schmid, U.;Goeldner, R.-G.;Strelkowa, N.;Huang, D.C.-L.;Bogenrieder, T.;Twelves, C.;Cheng, A.-L. |
| 國立成功大學 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, L.-T.;Martinelli, E.;Cheng, A.-L.;Pentheroudakis, G.;Qin, S.;Bhattacharyya, G.S.;Ikeda, M.;Lim, H.-Y.;Ho, G.F.;Choo, S.P.;Ren, Z.;Malhotra, H.;Ueno, M.;Ryoo, B.-Y.;Kiang, T.C.;Tai, D.;Vogel, A.;Cervantes, A.;Lu, S.-N.;Yen, C.-J.;Huang, Y.-H.;Chen, S.-C.;Hsu, C.;Shen, Y.-C.;Tabernero, J.;Yen, Yen Y.;Hsu, C.-H.;Yoshino, T.;Douillard, J.-Y. |
| 國立成功大學 |
2020 |
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies
|
Yen, C.-J.;Kudo, M.;Lim, H.-Y.;Hsu, C.-H.;Vogel, A.;Brandi, G.;Cheng, R.;Nitu, I.S.;Abada, P.;Hsu, Y.;Zhu, A.X.;Kang, Y.-K. |
| 國立成功大學 |
2020 |
A selective Aurora-A 5′-UTR siRNA inhibits tumor growth and metastasis
|
Lai, C.-H.;Chen, R.-Y.;Hsieh, Hsieh H.-P.;Tsai, S.-J.;Chang, K.-C.;Yen, C.-J.;Huang, Y.-C.;Liu, Y.-W.;Lee, J.-C.;Lai, Y.-C.;Hung, L.-Y.;Lin, B.-W. |
| 國立成功大學 |
2020 |
Investigating the health disparities in the association between lifestyle behaviors and the risk of head and neck cancer
|
Hsiao, J.-R.;Huang, C.-C.;Ou, C.-Y.;Chang, Chang C.-C.;Lee, W.-T.;Tsai, S.-T.;Huang, J.-S.;Chen, K.-C.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2020 |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Lin, J.;Hsieh, R.-K.;Chen, J.-S.;Lee, K.-D.;Rau, K.-M.;Shao, Y.-Y.;Sung, Y.-C.;Yeh, S.-P.;Chang, Chang C.-S.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Yen, C.-J.;Lai, P.-Y.;Hwang, W.-L.;Chiou, T.-J. |
| 國立成功大學 |
2020 |
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
|
Desai, J.;Deva, S.;Lee, J.S.;Lin, C.-C.;Yen, C.-J.;Chao, Y.;Keam, B.;Jameson, M.;Hou, M.-M.;Kang, Y.-K.;Markman, B.;Lu, C.-H.;Rau, K.-M.;Lee, K.-H.;Horvath, L.;Friedlander, M.;Hill, A.;Sandhu, Sandhu S.;Barlow, P.;Wu, C.-Y.;Zhang, Y.;Liang, Liang L.;Wu, J.;Paton, V.;Millward, Millward M. |
| 國立成功大學 |
2020 |
Phase I dose-escalation and -expansion study of telisotuzumab (ABT-700), an Anti-c-met antibody, in patients with advanced solid tumors
|
Strickler, J.H.;LoRusso, P.;Salgia, R.;Kang, Y.-K.;Yen, C.J.;Lin, C.-C.;Ansell, P.;Motwani, Motwani M.;Wong, S.;Yue, H.;Wang, L.;Reilly, E.;Afar, D.;Naumovski, L.;Ramanathan, Ramanathan R.K. |
| 國立成功大學 |
2020 |
Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study
|
Lin, C.-C.;Yang, T.-S.;Yen, C.-J.;Cheng, R.;Liu, J.;Hsu, C. |
| 國立成功大學 |
2020 |
Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma
|
Liao, W.-Y.;Hsu, C.-C.;Chan, T.-S.;Yen, C.-J.;Chen, W.-Y.;Pan, H.-W.;Tsai, K.K. |
| 國立成功大學 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, N.-J.;Chen, M.-H.;Yang, S.-H.;Hsu, C.;Yen, C.-J.;Tsou, H.-H.;Su, Y.-Y.;Chen, J.-S.;Shan, Y.-S.;Chen, L.-T. |
| 臺大學術典藏 |
2019 |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3-5 chronic kidney disease
|
Chou Y.-H.;Yen C.-J.;Lai T.-S.;Yung-Ming Chen; Chou Y.-H.; Yen C.-J.; Lai T.-S.; YUNG-MING CHEN |
| 臺大學術典藏 |
2019 |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3–5 chronic kidney disease
|
Chen Y.-M.; TAI-SHUAN LAI; Chou Y.-H.; Yen C.-J. |
| 臺大學術典藏 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; CHIUN HSU; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 國立成功大學 |
2019 |
Effect of First-line S-1 Plus Oxaliplatin with or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial
|
Yoshikawa, T.;Muro, K.;Shitara, K.;Oh, D.-Y.;Kang, Y.-K.;Chung, H.C.;Kudo, T.;Chin, K.;Kadowaki, S.;Hamamoto, Y.;Hironaka, S.;Yoshida, K.;Yen, C.-J.;Omuro, Y.;Bai, L.-Y.;Maeda, K.;Ozeki, A.;Yoshikawa, R.;Kitagawa, Y. |
| 國立成功大學 |
2019 |
Oral hygiene and the overall survival of head and neck cancer patients
|
Chang, Chang C.-C.;Lee, W.-T.;Hsiao, J.-R.;Ou, C.-Y.;Huang, C.-C.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2019 |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou, W.-C.;Chen, J.-S.;Hung, C.-Y.;Lu, C.-H.;Shao, Y.-Y.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Yeh, S.-P.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Hsieh, R.-K. |
| 國立成功大學 |
2019 |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu, Lu L.-C.;Hsu, C.;Shao, Y.-Y.;Chao, Y.;Yen, C.-J.;Shih, I.-L.;Hung, Y.-P.;Chang, Chang C.-J.;Shen, Y.-C.;Guo, J.-C.;Liu, T.-H.;Hsu, C.-H.;Cheng, A.-L. |
| 國立成功大學 |
2019 |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin, S.;Chan, S.L.;Sukeepaisarnjaroen, W.;Han, G.;Choo, S.P.;Sriuranpong, V.;Pan, H.;Yau, T.;Guo, Y.;Chen, M.;Ren, Z.;Xu, J.;Yen, C.-J.;Lin, Z.-Z.;Manenti, L.;Gu, Y.;Sun, Y.;Tiedt, R.;Hao, L.;Song, W.;Tanwandee, Tanwandee T. |
| 國立成功大學 |
2019 |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Cho, S.-F.;Rau, K.-M.;Shao, Y.-Y.;Yen, C.-J.;Wu, M.-F.;Chen, J.-S.;Chang, Chang C.-S.;Yeh, S.-P.;Chiou, T.-J.;Hsieh, R.-K.;Lee, M.-Y.;Sung, Y.-C.;Lee, K.-D.;Lai, P.-Y.;Yu, M.-S.;Hwang, W.-L.;Liu, T.-C. |
| 國立成功大學 |
2019 |
Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editing
|
Huo, Z.;Tu, J.;Xu, A.;Li, Y.;Wang, D.;Liu, M.;Zhou, R.;Zhu, D.;Lin, Y.;Gingold, J.A.;Yen, C.-J.;Xiao, H.;Zhao, R. |
| 國立成功大學 |
2019 |
The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol-metabolizing genes on the survival of head and neck cancer patients
|
Lee, W.-T.;Hsiao, J.-R.;Ou, C.-Y.;Huang, C.-C.;Chang, Chang C.-C.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
显示项目 346-370 / 471 (共19页)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每页显示[10|25|50]项目
|
